Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Holtzman

Showing results (671-680 of 743) with videos related to

Pageof 75
Sort By:
Science Translational Medicine|March 7, 2014
Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's diseaseAnne M Fagan, Chengjie Xiong, Mateusz S Jasielec, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 25, 2017
Preclinical Alzheimer's disease and longitudinal driving declineCatherine M Roe, Ganesh M Babulal, Denise M Head, et al.
Nature Communications|July 2, 2024
Baseline levels and longitudinal changes in plasma Aβ42/40 among Black and white individualsChengjie Xiong, Jingqin Luo, David A Wolk, et al.
Brain Communications|March 20, 2024
Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in Alzheimer's diseaseKarin L Meeker, Patrick H Luckett, Nicolas R Barthélemy, et al.
Science Advances|April 3, 2024
CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderlyFrancis Shue, Launia J White, Rachel Hendrix, et al.
Annals of Neurology|February 24, 2024
Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom OnsetYan Li, Daniel Yen, Rachel D Hendrix, et al.
Nature Medicine|January 15, 2020
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's diseaseYingyue Zhou, Wilbur M Song, Prabhakar S Andhey, et al.
JAMA Network Open|December 12, 2019
Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer DiseaseJorge J Llibre-Guerra, Yan Li, Suzanne E Schindler, et al.
Nature Medicine|May 16, 2020
Author Correction: Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's diseaseYingyue Zhou, Wilbur M Song, Prabhakar S Andhey, et al.
JCI Insight|May 2, 2023
KATP channels are necessary for glucose-dependent increases in amyloid-β and Alzheimer's disease-related pathologyJohn Grizzanti, William R Moritz, Morgan C Pait, et al.
Pageof 75

Showing results (671-680 of 743) with videos related to

Sort By:
Pageof 75
Science Translational Medicine|March 7, 2014
Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's diseaseAnne M Fagan, Chengjie Xiong, Mateusz S Jasielec, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 25, 2017
Preclinical Alzheimer's disease and longitudinal driving declineCatherine M Roe, Ganesh M Babulal, Denise M Head, et al.
Nature Communications|July 2, 2024
Baseline levels and longitudinal changes in plasma Aβ42/40 among Black and white individualsChengjie Xiong, Jingqin Luo, David A Wolk, et al.
Brain Communications|March 20, 2024
Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in Alzheimer's diseaseKarin L Meeker, Patrick H Luckett, Nicolas R Barthélemy, et al.
Science Advances|April 3, 2024
CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderlyFrancis Shue, Launia J White, Rachel Hendrix, et al.
Annals of Neurology|February 24, 2024
Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom OnsetYan Li, Daniel Yen, Rachel D Hendrix, et al.
Nature Medicine|January 15, 2020
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's diseaseYingyue Zhou, Wilbur M Song, Prabhakar S Andhey, et al.
JAMA Network Open|December 12, 2019
Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer DiseaseJorge J Llibre-Guerra, Yan Li, Suzanne E Schindler, et al.
Nature Medicine|May 16, 2020
Author Correction: Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's diseaseYingyue Zhou, Wilbur M Song, Prabhakar S Andhey, et al.
JCI Insight|May 2, 2023
KATP channels are necessary for glucose-dependent increases in amyloid-β and Alzheimer's disease-related pathologyJohn Grizzanti, William R Moritz, Morgan C Pait, et al.
Pageof 75